Concourse Financial Group Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Concourse Financial Group Securities’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-165	Closed	-$19.3K	–	2503
2021 Q2	$23K	Hold	165	–	–	﹤0.01%	1612
2021 Q1	$16K	Hold	165	–	–	﹤0.01%	1639
2020 Q4	$20K	Hold	165	–	–	﹤0.01%	1470
2020 Q3	$16K	Hold	165	–	–	﹤0.01%	1438
2020 Q2	$26K	Hold	165	–	–	﹤0.01%	1212
2020 Q1	$24K	Hold	165	–	–	﹤0.01%	1181
2019 Q4	$34K	Hold	165	–	–	﹤0.01%	1084
2019 Q3	$13K	Hold	165	–	–	﹤0.01%	1088
2019 Q2	$16K	Hold	165	–	–	﹤0.01%	1343
2019 Q1	$14K	Hold	165	–	–	﹤0.01%	1412
2018 Q4	$9K	Hold	165	–	–	﹤0.01%	1473
2018 Q3	$13K	Buy	+165	New	+$11.6K	﹤0.01%	1020

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Concourse Financial Group Securities's RETA Position: Q3 2021 in Review

Concourse Financial Group Securities sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2021, closing a stake of 165 shares — an estimated $19.3K sold.

Concourse Financial Group Securities first reported a position in RETA in Q3 2018 and held it in 12 quarters. The position peaked at $34K in Q4 2019. 181 funds tracked by Wall St. Rank hold RETA as of Q3 2021.

Concourse Financial Group Securities reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Concourse Financial Group Securities sold 165 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2021, an estimated $19.3K.
Concourse Financial Group Securities first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2018 and held it in 12 quarters.
Concourse Financial Group Securities's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $34K in Q4 2019.
181 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2021.

Based on Concourse Financial Group Securities's 13F filing for Q3 2021, filed 9 Nov 2021.